Modifying the risk: Once-a-day bathing “at risk” patients in the intensive care unit with chlorhexidine digluconate - American Journal of Infection Control |
Chlorhexidine digluconate decreases hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) that can cause colonization and infection. A standard approach is the bathing of all patients with chlorhexidine digluconate to prevent MRSA transmission. To decrease CHG utilization, this study assessed selective daily administration of chlorhexidine digluconate bathing to intensive care unit patients who had an MRSA-positive result or a central venous catheter. This risk-based approach was associated with a 72% decrease in hospital-acquired MRSA transmission rate. |
【Back】 |